User profiles for Venky Soundararajan

Venky Soundararajan

Founder & Chief Scientific Officer - nference, Anumana, Pramana, Vimana
Verified email at nference.net
Cited by 2376

Benchmarking evolutionary tinkering underlying human–viral molecular mimicry shows multiple host pulmonary–arterial peptides mimicked by SARS-CoV-2

…, AD Badley, GM Church, V Soundararajan - Cell death …, 2020 - nature.com
The hand of molecular mimicry in shaping SARS-CoV-2 evolution and immune evasion
remains to be deciphered. Here, we report 33 distinct 8-mer/9-mer peptides that are identical …

SARS-CoV-2 strategically mimics proteolytic activation of human ENaC

…, AJ Venkatakrishnan, V Soundararajan - Elife, 2020 - elifesciences.org
Molecular mimicry is an evolutionary strategy adopted by viruses to exploit the host cellular
machinery. We report that SARS-CoV-2 has evolved a unique S1/S2 cleavage site, absent in …

[PDF][PDF] Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection

…, AD Badley, AJ Venkatakrishnan, V Soundararajan - Med, 2022 - cell.com
Background mRNA coronavirus disease 2019 (COVID-19) vaccines are safe and effective,
but increasing reports of breakthrough infections highlight the need to vigilantly monitor and …

[HTML][HTML] Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence

…, AD Badley, AJ Venkatakrishnan, V Soundararajan - MedRxiv, 2021 - ncbi.nlm.nih.gov
Although clinical trials and real-world studies have affirmed the effectiveness and safety of
the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent …

[PDF][PDF] FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system

…, MD Swift, AD Badley, J Halamka, V Soundararajan - Med, 2021 - cell.com
… Badley,2 John Halamka,2 and Venky Soundararajan1,4,* … for information should be
directed to and will be fulfilled by the lead contact, Venky Soundararajan (venky@nference.net). …

Analysis of the effectiveness of the Ad26. COV2. S adenoviral vector vaccine for preventing COVID-19

…, A Virk, MD Swift, T Wagner, V Soundararajan - JAMA network …, 2021 - jamanetwork.com
Importance Continuous assessment of the effectiveness and safety of the US Food and Drug
Administration–authorized SARS-CoV-2 vaccines is critical to amplify transparency, build …

Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations

…, J Halamka, AD Badley, V Soundararajan - Scientific reports, 2021 - nature.com
Clinical studies are ongoing to assess whether existing vaccines may afford protection
against SARS-CoV-2 infection through trained immunity. In this exploratory study, we analyze …

Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis

…, WG Morice, J Halamka, A Badley, V Soundararajan - Elife, 2020 - elifesciences.org
Understanding temporal dynamics of COVID-19 symptoms could provide fine-grained resolution
to guide clinical decision-making. Here, we use deep neural networks over an institution…

A literature-derived knowledge graph augments the interpretation of single cell RNA-seq datasets

…, A Anand, R Barve, V Thiagarajan, V Soundararajan - Genes, 2021 - mdpi.com
Technology to generate single cell RNA-sequencing (scRNA-seq) datasets and tools to
annotate them have advanced rapidly in the past several years. Such tools generally rely on …

Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin

The emergence of a heavily mutated SARS-CoV-2 variant (B. 1.1. 529, Omicron) and it’s
spread to 6 continents within a week of initial discovery has set off a global public health alarm. …